News from Zyme and the companies we work with.

August 22, 17

Owlstone Medical’s disease breathalyzer, ReCIVA, to feature in Tomorrow’s World gallery at the Science Museum, London

Recognizes potential of the breath biopsy platform to transform diagnostics ReCIVA Breath Sampler will be on display from Friday August 18th, 2017 Cambridge, UK, August 22nd, 2017: Owlstone Medical, a diagnostics company, today announced that its disease breathalyzer, ReCIVA™ has … Continue reading

August 16, 17

Abcam and TTP Labtech Collaborate to Develop sol-R Reagent Kits

Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research Cambridge, UK, 16 August 2017:  TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, and Abcam plc, … Continue reading

August 15, 17

Cambridge Epigenetix and NuGEN Technologies sign partnership agreement to combine leading technologies in epigenetics research

Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl® technology for oxidative bisulfite sequencing (oxBS-Seq) with Targeted Methylation and NuGEN Ovation Methyl-Seq systems Cambridge, UK, August 15, 2017:  Cambridge Epigenetix (CEGX)  and  NuGEN Technologies, leaders in innovative epigenetic technologies, today announced that they … Continue reading

August 10, 17

Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

New headquarters strengthen drug discovery services and translational research, and generate new employment opportunities in Scotland  Glasgow, UK. 10th August 2017: REPROCELL Europe Ltd (REPROCELL), a leading provider of products and services for research in stem cells, drug discovery, human … Continue reading

August 1, 17

Horizon Discovery announces release of high quality, well annotated CHO genome sequence to drive innovation in bioproduction

Genome sequence is based on Horizon’s Glutamine Synthetase (GS) Knock-Out CHO K1 manufacturing-ready cell line Sequenced in collaboration with the Wellcome Trust Sanger Institute, this high value reference tool enables the industry to screen for genes associated with desired phenotypes … Continue reading

August 1, 17

Zyme Communications Strengthens Team and Relocates Cambridge Office

Zyme Moves to Cambridge Innovation Park and Appoints Dr Michelle Ricketts and Lily Jeffery 01 August 2017, Cambridge, UK: Zyme Communications Ltd (Zyme), the public relations and marketing agency specialising in the life science sector, announced it has relocated its … Continue reading

July 31, 17

New England Biolabs® and TTP plc collaborate to provide services for molecular diagnostics

New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products Cambridge, UK, and Ipswich MA, July 31st 2017  - TTP plc, a leading technology and product development company, and New England … Continue reading

July 31, 17

TTP Plc introduces FormaJet liquid handling platform for high throughput digital bioprinting

Novel droplet dispensing concept will enable high-speed, high-density, many-colour printing in emerging applications including diagnostics, tissue engineering and drug discovery Cambridge, UK, 31st July 2017: TTP Plc (TTP), a leading independent technology and product development company, is seeking development and … Continue reading

July 31, 17

Boost for NHS Innovation as Medtech Accelerator Announce First Award Winners

Three pioneering projects share £200K in new early stage financial awards scheme Cambridge, UK, 31 July 2017 – The Medtech Accelerator, a new company set up to provide proof of concept financial awards to support development of medical technology and … Continue reading

July 31, 17

LifeArc and Metrion Biosciences extend partnership agreement to support LifeArc’s neuroscience small molecule drug discovery programme

Metrion to provide in-depth ion channel target class knowledge and assay support  Cambridge, UK, 31 July 2017: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, the UK medical research charity previously known as … Continue reading